Abstract
Glycosylation is the most common posttranslational modification of proteins and plays diverse roles in numerous biological processes, including fertilization, development, differentiation, inflammation, cancer metastasis, and host-pathogen/-parasite interactions. A number of glycosylated proteins are bioactive molecules of medical/therapeutic or other commercial interest and are currently produced by recombinantly transformed cells and organisms. Among non-animal expression systems, plant cells and transgenic plants are considered an attractive alternative system for recombinant human and animal glycoproteins. The advantages of using plants for the production of commercially important glycosylated proteins include lower manufacturing costs and a reduced risk of transmitting mammalian pathogens [11, 27]. However, a major roadblock in the use of plants for this purpose is the lack of available information on N- and O-linked glycans in plants and specifically those in the endogenous plant glycosylation pathways [9, 31]. Thus, gathering detailed structural information on plant-derived glycoproteins is of utmost importance.
| Original language | English (Ireland) |
|---|---|
| Pages (from-to) | 257-269 |
| Number of pages | 13 |
| Journal | Advances In Experimental Medicine & Biology |
| Volume | 705 |
| DOIs | |
| Publication status | Published - 1 Jan 2011 |
Keywords
- Carbohydrate
- Glycoprotein
- Glycosylation
- Lectins
- Non-carbohydrate-mediated binding
- Non-mammalian
- Plant protein